These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 26631082)
1. Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model. Qu Y; Qiu Z; Cao C; Lu Y; Sun M; Liang C; Zeng Z BMC Vet Res; 2015 Dec; 11():294. PubMed ID: 26631082 [TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens. Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665 [TBL] [Abstract][Full Text] [Related]
3. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling. Dorey L; Pelligand L; Lees P BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426 [TBL] [Abstract][Full Text] [Related]
4. Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets. Zeng QL; Mei X; Su J; Li XH; Xiong WG; Lu Y; Zeng ZL BMC Vet Res; 2017 Jun; 13(1):178. PubMed ID: 28619095 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle. Shan Q; Wang J; Yang F; Ding H; Liang C; Lv Z; Li Z; Zeng Z J Vet Pharmacol Ther; 2014 Jun; 37(3):222-30. PubMed ID: 24033339 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida. Potter T; Illambas J; Pelligand L; Rycroft A; Lees P Vet J; 2013 Jan; 195(1):53-8. PubMed ID: 23084327 [TBL] [Abstract][Full Text] [Related]
7. Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens. Dorey L; Lees P BMC Vet Res; 2017 Jun; 13(1):192. PubMed ID: 28645327 [TBL] [Abstract][Full Text] [Related]
8. Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida. Dorey L; Hobson S; Lees P Res Vet Sci; 2017 Apr; 111():93-98. PubMed ID: 28113129 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic integration of marbofloxacin after single and repeated intravenous administration in goats. Bhardwaj P; Sidhu PK; Lonare MK; Kaur R; Dumka VK; Rampal S Res Vet Sci; 2018 Dec; 121():111-115. PubMed ID: 30384141 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease. Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438 [TBL] [Abstract][Full Text] [Related]
11. Comparative pharmacokinetics of danofloxacin in healthy and Pasteurella multocida infected ducks. Xiao X; Lan W; Wang Y; Jiang L; Jiang Y; Wang Z J Vet Pharmacol Ther; 2018 Dec; 41(6):912-918. PubMed ID: 30182430 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic-pharmacodynamic relationship of marbofloxacin for Escherichia coli and Pasturella multocida following repeated intramuscular administration in goats. Bhardwaj P; Sidhu PK; Saini SPS; M B D; Rampal S J Vet Pharmacol Ther; 2019 Jul; 42(4):430-439. PubMed ID: 31102281 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida. Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418 [TBL] [Abstract][Full Text] [Related]
14. Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys. Haritova AM; Rusenova NV; Parvanov PR; Lashev LD; Fink-Gremmels J Antimicrob Agents Chemother; 2006 Nov; 50(11):3779-85. PubMed ID: 16940071 [TBL] [Abstract][Full Text] [Related]
15. Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves. Balaje RM; Sidhu PK; Kaur G; Rampal S Res Vet Sci; 2013 Dec; 95(3):1114-24. PubMed ID: 23941961 [TBL] [Abstract][Full Text] [Related]
16. A new pleuromutilin candidate with potent antibacterial activity against Pasteurella multocida. Fu Y; Ma L; Yi Y; Fan Y; Liang J; Shang R Microb Pathog; 2019 Feb; 127():202-207. PubMed ID: 30529392 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic/pharmacodynamic integration of cefquinome against Pasteurella Multocida in a piglet tissue cage model. Zhang L; Wu X; Huang Z; Kang Z; Chen Y; Shen X; Cai Q; Ding H J Vet Pharmacol Ther; 2019 Jan; 42(1):60-66. PubMed ID: 30407642 [TBL] [Abstract][Full Text] [Related]
18. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media. Dorey L; Hobson S; Lees P Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285 [TBL] [Abstract][Full Text] [Related]
19. In vitro Dynamic Pharmacokinetic/Pharmacodynamic (PK/PD) study and COPD of Marbofloxacin against Haemophilus parasuis. Sun J; Xiao X; Huang RJ; Yang T; Chen Y; Fang X; Huang T; Zhou YF; Liu YH BMC Vet Res; 2015 Dec; 11():293. PubMed ID: 26626889 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection. Xiao XM; Xiao YH Acta Pharmacol Sin; 2008 Oct; 29(10):1253-60. PubMed ID: 18817632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]